Analytical Method Validation in FDA process - 2017

Website http://www.compliance4all.com/control/w_product/~product_id=501215LIVE?channel=mailer&camp=Webinar&A | Edit Freely

Category pharmaceutical, Medical device compliance webinar, medical device calibration requirements, pharmaceutical manufacturing, largest pharmaceutical companies, Fda compliance guidelines, Analytical Method Validation, method validation

Deadline: April 24, 2017 | Date: April 25, 2017

Venue/Country: Fremont, U.S.A

Updated: 2017-02-24 19:02:13 (GMT+9)

Call For Papers - CFP

An analytical method is a process. The FDA process validation guidance applies to test methods, like all other processes in the pharmaceutical industry. Therefore, the laboratory or laboratories must demonstrate that a test method performs as intended through the method lifecycle.

Why should you Attend:

Observations that test methods are inadequate or the firm does not have appropriate data that demonstrates the method performs as intended rank high on the list of observations in the laboratory.

Areas Covered in the Session:

FDA System Based Inspection Guidance

Laboratory Control System

Most common observations in the laboratory

Warning letter observations and analysis

Who Will Benefit:

Quality Control Manager

Supervisors

Analysis and Microbiologists

Speaker Profile:

John (Jerry) Lanese is an independent consultant with a focus on Quality Systems and the components of an effective Quality System. He received a BA and MS from Middlebury College and a Ph.D. in Analytical Chemistry from the University of Michigan and began his career teaching Analytical Chemistry in a small liberal arts college. Dr. Lanese moved from the academic environment to the pharmaceutical industry where he has managed Analytical Research, Quality Control and Quality Assurance functions.

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: supportcompliance4All.com